Literature DB >> 31562553

Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion.

Gaku Izumi1, Atsuhito Takeda2, Hirokuni Yamazawa2, Osamu Sasaki2, Nobuyasu Kato3, Hidetsugu Asai3, Tsuyoshi Tachibana3, Yoshiro Matsui3.   

Abstract

Recent reports suggested that cardiopulmonary bypass (CPB) time is one of the risk factors for postoperative complications after Fontan conversion. Although Fontan conversion may be performed for the patients with hepatic fibrosis after initial Fontan procedure, there is no predictive indicator regarding the liver function associated with hemostasis which can affects CPB time. Thirty-one patients who underwent Fontan conversion using the same surgical procedure (extracardiac conduit conversion with right atrium exclusion) were enrolled. In multivariate analyses including age at Fontan conversion, interval from initial Fontan to conversion, hemodynamic data such as right atrial pressure, ventricular end-diastolic pressure, and cardiac index, hepatic data such as platelet count, prothrombin time international normalized ratios, serum total bilirubin, hyaluronic acid levels, five known indices for hepatic fibrosis (Forns Index, APRI, FIB4, FibroIndex, and MELD-XI), and liver stiffness measured by ultrasound elastography, only the Forns Index remained independently associated with the CPB time (P < 0.01) and blood transfusions (plasma transfusions and platelet concentrations: P < 0.01 for both). The cutoff level for Forns Index to predict the prolonged CPB time (exceeding 240 min) was 4.85 by receiver-operating characteristic curve (area under the curve 0.823, sensitivity 76.9%, and specificity 72.2%). Three patients with Forns Index > 7.0 had poor outcomes with long CPB time and massive blood transfusions in contrast with the other 28 patients. In conclusion, Forns Index could serve as a practical predictor of CPB time and is associated with blood transfusion volume in Fontan conversion.

Entities:  

Keywords:  Cardiopulmonary bypass time; Fontan conversion; Forns Index; Hemostasis; Liver function

Mesh:

Substances:

Year:  2019        PMID: 31562553     DOI: 10.1007/s00380-019-01515-w

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  30 in total

1.  FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C.

Authors:  Masahiko Koda; Yoshiko Matunaga; Manri Kawakami; Yukihiro Kishimoto; Takeaki Suou; Yoshikazu Murawaki
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

2.  J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes.

Authors:  Constantine Mavroudis; Barbara J Deal; Carl L Backer; Robert D Stewart; Wayne H Franklin; Sabrina Tsao; Kendra M Ward; R Andrew DeFreitas
Journal:  Ann Thorac Surg       Date:  2007-11       Impact factor: 4.330

Review 3.  Delicate balance of bleeding and thrombosis in end-stage liver disease and liver transplantation.

Authors:  Fuat Hakan Saner; Robert K Gieseler; Hikmet Akız; Ali Canbay; Klaus Görlinger
Journal:  Digestion       Date:  2013-09-05       Impact factor: 3.216

4.  Fontan conversion to cavopulmonary connection and arrhythmia circuit cryoblation.

Authors:  C Mavroudis; C L Backer; B J Deal; C L Johnsrude
Journal:  J Thorac Cardiovasc Surg       Date:  1998-03       Impact factor: 5.209

5.  Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial.

Authors:  Ludhmila A Hajjar; Jean-Louis Vincent; Filomena R B G Galas; Rosana E Nakamura; Carolina M P Silva; Marilia H Santos; Julia Fukushima; Roberto Kalil Filho; Denise B Sierra; Neuza H Lopes; Thais Mauad; Aretusa C Roquim; Marcia R Sundin; Wanderson C Leão; Juliano P Almeida; Pablo M Pomerantzeff; Luis O Dallan; Fabio B Jatene; Noedir A G Stolf; Jose O C Auler
Journal:  JAMA       Date:  2010-10-13       Impact factor: 56.272

6.  The clinical characteristics of sudden cardiac arrest in asymptomatic patients with congenital heart disease.

Authors:  Aya Miyazaki; Heima Sakaguchi; Hideo Ohuchi; Kenji Yasuda; Nobuyuki Tsujii; Michio Matsuoka; Tetsuya Yamamoto; Satoshi Yazaki; Etsuko Tsuda; Osamu Yamada
Journal:  Heart Vessels       Date:  2013-11-27       Impact factor: 2.037

Review 7.  Influence of cirrhosis in cardiac surgery outcomes.

Authors:  Juan C Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Josep L Ventura; Rafael Mañez; Elisabet Farrero; Herminia Torrado; David Rodríguez-Castro; Maria L Carrio
Journal:  World J Hepatol       Date:  2015-04-18

8.  Predictive risk factors for patients with cirrhosis undergoing heart surgery.

Authors:  Rawa Arif; Philipp Seppelt; Simon Schwill; Dubravka Kojic; Ali Ghodsizad; Arjang Ruhparwar; Matthias Karck; Klaus Kallenbach
Journal:  Ann Thorac Surg       Date:  2012-08-24       Impact factor: 4.330

9.  40-Year Follow-Up After the Fontan Operation: Long-Term Outcomes of 1,052 Patients.

Authors:  Kavitha N Pundi; Jonathan N Johnson; Joseph A Dearani; Krishna N Pundi; Zhuo Li; Cynthia A Hinck; Sonja H Dahl; Bryan C Cannon; Patrick W O'Leary; David J Driscoll; Frank Cetta
Journal:  J Am Coll Cardiol       Date:  2015-10-13       Impact factor: 24.094

10.  Serum hyaluronic acid concentration in Fontan circulation: correlation with hepatic function and portal vein hemodynamics.

Authors:  Taiyu Hayashi; Ryo Inuzuka; Takahiro Shindo; Yoichiro Hirata; Nobutaka Shimizu; Akira Oka
Journal:  Pediatr Cardiol       Date:  2013-10-26       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.